JPMorgan hit by hackers, GlaxoSmithKline ebola vaccine coming, Abercrombie getting waxed

Jeff Macke
August 28, 2014

JPMorgan (JPM): The biggest bank in the U.S. dipping lower today after confirming that it was the victim of a malware attack that exposed customer data. As many as four other banks were also effected. Rather disturbingly government officials suspect the source of the attacks is based in Russia. JPMorgan says they have multiple layers of security and they face attacks just about every day. Rather cold comfort, that.

GlaxoSmithKline (GSK): Shares are slightly higher on word that its ebola vaccine could enter human trials as early as next month. World Health Organization officials announced overnight that the disease continues to spread, with more than 40% of all cases developing in the last three weeks. If trials of the vaccine are effective Glaxo will make as many as ten thousand doses available to the WHO for volunteers in high risk areas.

Abercrombie & Fitch (ANF): Shares getting waxed to the tune of more than 5% after the skeevy teenwear maker beat earnings estimates but reported weak sales. Comps fell by an appalling 8% in the U-S and 16% internationally. CEO Mike Jeffries blamed "adverse likes" of logo'd merchandise, a category customers have been adverse liking aggressively for several years. Despite today's drop Abercrombie shares are still more than 35% higher for 2014.

More from Investing:

Why Boeing, Caterpillar & GE need Export-Import bank to compete

Stocks at new highs is uncharted territory for investors: Karabell

Tiffany shines, Express in the fast lane, Facebook gets un-liked